Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro.

Antimicrobial Agents and Chemotherapy
E M ScottR M McCrory

Abstract

The combination of fluconazole with either ibuprofen, sodium salicylate, or propylparaben resulted in synergistic activity (fractional inhibitory index, < 0.5) against Candida albicans NCYC 620 in a microdilution checkerboard assay. Synergism between miconazole and ibuprofen was also demonstrated. In three or four clinical isolates of C. albicans from AIDS patients, the combination of fluconazole and ibuprofen was synergistic. Preparation of the inoculum and the growth conditions used were those recommended by the National Committee for Clinical Laboratory Standards for susceptibility testing. A visual estimation of total inhibition of growth and determination of an 80% reduction in the optical density at 492 nm compared with those for the control were taken as endpoints for the calculation of synergy, and a good correlation between both estimates was demonstrated.

Citations

Oct 2, 2009·Current Microbiology·Sarit Oriel, Yeshayahu Nitzan
Nov 25, 2000·The International Journal of Biochemistry & Cell Biology·C T PriceJ E Gustafson
Feb 5, 2013·The Journal of Antimicrobial Chemotherapy·Ute ZeidlerChristophe d'Enfert
Oct 12, 2011·Antimicrobial Agents and Chemotherapy·Marisa H MiceliSamuel A Lee
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Ruth C MatthewsJames Burnie
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Mohammed A S Alem, L Julia Douglas
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Melissa D JohnsonJohn H Rex
Jun 30, 2011·Folia Microbiologica·Andreza Urba de QuadrosMarta Chagas Monteiro
Jun 26, 2004·Journal of Chemotherapy·S StepanovićL Ranin
Jul 11, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Makoto UraiYoshitsugu Miyazaki
Aug 16, 2011·Diagnostic Microbiology and Infectious Disease·Tarcieli P VenturiniSydney Hartz Alves
Jul 28, 2016·Virulence·Arielle ButtsP David Rogers
Dec 18, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·C Pina-VazJ Martinez-de-Oliveira
Jan 10, 2018·Antimicrobial Agents and Chemotherapy·Parth N ShahCarolyn L Cannon
Dec 22, 2017·Antimicrobial Agents and Chemotherapy·Hassan E EldesoukyMohamed N Seleem
Dec 3, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mariele Caroline Marques Nogueira PuhlBenedito Prado Dias Filho
Sep 16, 1998·Antimicrobial Agents and Chemotherapy·G E McElhaney-FeserR L Cihlar
Jun 10, 2021·Infection and Drug Resistance·Wenli FengShaoyan Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.